SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-018626
Filing Date
2023-06-27
Accepted
2023-06-27 16:28:29
Documents
14
Period of Report
2023-06-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20230615_8k.htm   iXBRL 8-K 45389
2 AMENDED AND RESTATED OUTSIDE DIRECTOR COMPENSATION POLICY ex_538611.htm EX-10.1 32318
  Complete submission text file 0001437749-23-018626.txt   223390

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20230627.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20230627_def.xml EX-101.DEF 11804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20230627_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20230627_pre.xml EX-101.PRE 12019
8 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20230615_8k_htm.xml XML 2637
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 231047650
SIC: 2834 Pharmaceutical Preparations